Answers are grounded in this paper and cite their sources.
A recent meta-analysis 1,2 and a prospective study 3 reported that bacterial coinfection and secondary infection among patients with COVID-19 infection are uncommon. However, in these studies, antimicrobial drugs were prescribed for approximately 70% of patients with the disease. 2 Therefore, data are needed on patients with COVID-19 infection who do not routinely receive an antimicrobial drug prescription, to identify the true rate of concurrent infection in this patient population. At the
No takes yet. Share an insight, caveat, or question.
Komagamine et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: